A Resuscitated Case of Acute Myocardial Infarction with Both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency
Overview
Authors
Affiliations
A 56-year-old postmenopausal woman with out-of-hospital cardiac arrest caused by acute myocardial infraction was successfully resuscitated by intensive treatments and recovered without any neurological disability. She was diagnosed as having familial hypercholesterolemia (FH) based on a markedly elevated low-density lipoprotein cholesterol (LDL-C) level and family history of premature coronary artery disease. Genetic testing in her family members showed that a variant of the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene (c.2004C>A, p.S668R), which had been previously reported as having uncertain significance, was associated with FH, indicating that the variant is a potential candidate for the FH phenotype. Next-generation sequencing analysis for the proband also showed that there was a heterozygous mutation of the ATP-binding cassette sub-family G member 5 ( ABCG5) gene (c.1166G>A, R389H), which has been reported to increase LDL-C level and the risk of cardiovascular disease. She was also diagnosed as having type 1 CD36 deficiency based on a lack of myocardial uptake of I-labeled 15-(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid in scintigraphy and the absence of CD36 antigen in both monocytes and platelets in flow cytometry. She had a homozygous mutation of the CD36 gene (c.1126-5_1127delTTTAGAT), which occurs in a canonical splice site (acceptor) and is predicted to disrupt or distort the normal gene product. To our knowledge, this is the first report of a heterozygous FH phenotype caused by possibly oligogenic variants of the PCSK9 and ABCG5 genes complicated with type I CD36 deficiency caused by a novel homozygous mutation. Both FH phenotype and CD36 deficiency might have caused extensive atherosclerosis, leading to acute myocardial infarction in the present case.
Bartoszewicz M, Rac M Biomedicines. 2023; 11(5).
PMID: 37239003 PMC: 10216489. DOI: 10.3390/biomedicines11051332.
Quagliariello V, Bisceglia I, Berretta M, Iovine M, Canale M, Maurea C Cancers (Basel). 2023; 15(5).
PMID: 36900189 PMC: 10000232. DOI: 10.3390/cancers15051397.
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis.
di Taranto M, Fortunato G Int J Mol Sci. 2023; 24(4).
PMID: 36834635 PMC: 9961636. DOI: 10.3390/ijms24043224.
Iyama K, Ikeda S, Koga S, Yoshimuta T, Kawano H, Tsuji S Intern Med. 2021; 61(8):1169-1177.
PMID: 34615826 PMC: 9107993. DOI: 10.2169/internalmedicine.8288-21.